Evidence map›Paper›PMID 30262776›Full record

ArticleViruses2018

Considerations for Optimization of High-Throughput Sequencing Bioinformatics Pipelines for Virus Detection.

Christophe Lambert, Cassandra Braxton, Robert L Charlebois, Avisek Deyati, Paul Duncan, Fabio La Neve, Heather D Malicki, Sebastien Ribrioux, Daniel K Rozelle, Brandye Michaels and 3 more

Abstract read
In one paragraph

Article in Viruses, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Viral Clearance: Safety and Efficiency of Biopharmaceuticals.Therapeutic innovation & regulatory science · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Report of the third conference on next-generation sequencing for adventitious virus detection in biologics for humans and animals.Biologicals : journal of the International Association of Biological Standardization · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Christophe LambertGSK, 1330 Rixensart, Belgium. christophe.g.lambert@gsk.com.ORCID 0000-0002-7727-2018
Cassandra BraxtonBiogen Inc., Research Triangle Park, NC 27709, USA. cassandra.braxton@biogen.com.
Robert L CharleboisAnalytical Research and Development, Sanofi Pasteur, Toronto, ON M2R 3T4, Canada. Robert.Charlebois@sanofi.com.
Avisek DeyatiGSK, 1330 Rixensart, Belgium. avis.quest@gmail.com.
Paul DuncanMerck & Co. Inc., West Point, PA 19486, USA. paul_duncan@merck.com.
Fabio La NeveMerck KGaA, 10010 Torino, Italy. fabioinusa@gmail.com.ORCID 0000-0002-8422-3206
Heather D MalickiWuXi AppTec, Philadelphia, PA 19112, USA. Heather.Malicki@wuxiapptec.com.
Sebastien RibriouxGenedata AG, 4053 Basel, Switzerland. sebastien.ribrioux@genedata.com.
Daniel K RozelleRadiant Systems, Inc., Plainfield, NJ 07080, USA. dan.rozelle@gmail.com.
Brandye MichaelsAnalytical Research and Development: Microbiology, Pfizer Inc., Andover, MA 01810, USA. Brandye.Michaels@pfizer.com.
Wenping SunWuXi AppTec, Philadelphia, PA 19112, USA. kathryn.sun@gmail.com.
Zhihui YangOffice of Applied Research and Safety Assessment, Center for Food Safety and Applied Nutrition, U.S. Food and Drug Administration, Laurel, MD 20708, USA. Zhihui.Yang@fda.hhs.gov.
Arifa S KhanOffice of Vaccines Research and Review, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD 20993, USA. Arifa.Khan@fda.hhs.gov.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput sequencing (HTS) has demonstrated capabilities for broad virus detection based upon discovery of known and novel viruses in a variety of samples, including clinical, environmental, and biological. An important goal for HTS applications in biologics is to establish parameter settings that can afford adequate sensitivity at an acceptable computational cost (computation time, computer memory, storage, expense or/and efficiency), at critical steps in the bioinformatics pipeline, including initial data quality assessment, trimming/cleaning, and assembly (to reduce data volume and increase likelihood of appropriate sequence identification). Additionally, the quality and reliability of the results depend on the availability of a complete and curated viral database for obtaining accurate results; selection of sequence alignment programs and their configuration, that retains specificity for broad virus detection with reduced false-positive signals; removal of host sequences without loss of endogenous viral sequences of interest; and use of a meaningful reporting format, which can retain critical information of the analysis for presentation of readily interpretable data and actionable results. Furthermore, after alignment, both automated and manual evaluation may be needed to verify the results and help assign a potential risk level to residual, unmapped reads. We hope that the collective considerations discussed in this paper aid toward optimization of data analysis pipelines for virus detection by HTS.

Indexed as

Computational BiologyHigh-Throughput Nucleotide SequencingData AccuracyDatabases as TopicDNA, ViralReproducibility of ResultsResearch DesignRNA, ViralSequence AlignmentSequence AnalysisSoftwareVirusesDNA, ViralRNA, Viraladventitious virus detectionbioinformatics pipelinehigh-throughput sequencing

Identifiers

PMID30262776
PMCPMC6213042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.